2011 Presentations
Click on a presentation below to view. All presentations are password protected.- Aerie Pharmaceuticals - Thomas van HaarlemView Presentation
- Alimera Sciences - Dan MyersView Presentation
- Eleven Biotherapeutics - Abbie CelnikerView Presentation
- EyeGate Pharma - Stephen FromView Presentation
- EOS Neuroscience - Ben MatteoView Presentation
- iCo Therapeutics - Andrew RaeView Presentation
- Inotek Pharmaceutical Corp. - Paul HowesView Presentation
- MacuCLEAR - Philip RalstonView Presentation
- Mimetogen Pharmaceuticals - Garth CumberlidgeView Presentation
- Neurotech - Ted DanseView Presentation
- Promedior - Nick ColangeloView Presentation
Device Company Showcase Presentations
- AcuFocus - Ed PetersonView Presentation
- AkkoLens International - Michiel RombachView Presentation
- Avedro - David MullerView Presentation
- Implandata Ophthalmic Products - Max OstermeierView Presentation
- NeoVista - John HendrickView Presentation
- Ocular Therapeutix - Amar SawhneyView Presentation
- OD-OS - Winfried TeiwesView Presentation
- Power Vision - Barry CheskinView Presentation
- Revision Optics - John KilcoyneView Presentation
- Sensimed - Jean-Marc WismerView Presentation
- WaveTec Vision - Tom FrinziView Presentation
2011 - Year in Review
Emmett Cunningham, Jr., MD, PhD, MPH
Partner
Clarus Ventures, LLC
View Presentation
Benefit vs. Risk at the FDA
Malvina Eydelman, MD
Division of Ophthalmic, Neurological, & ENT Devices
Food & Drug Administration
View Presentation
A Public View of the Ophthalmic Sector
Anthony Gibney
Managing Director
Leerink Swann
View Presentation
Private Funding and Exit Trends in the Biotech and Medical Device Industries
Jon Norris
Managing Director
SVB Capital
View Presentation
Private Funding and Exits trends in Ophthalmology
Ellen Foster Licking
Executive Editor
Elsevier Business Intelligence
View Presentation
Ophthalmic Innovation in the 21st Century
Leslie Norwalk
Former Director
CMS
View Presentation
Staged Buyouts - Getting to "Win-Win"
Nick Galakatos, PhD
Managing Director
Clarus Ventures, LLC
View Presentation
Dry AMD - The Next Frontier
David Guyer, MD
Partner
SV Life Sciences
View Presentation